JYNT Fundamental Analysis - JOINT CORP/THE

Fundamental Rating

JYNT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for JYNT as it has an excellent financial health rating, but there are worries on the profitability. JYNT does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year JYNT has reported negative net income.

JYNT had a positive operating cash flow in the past year.

In multiple years JYNT reported negative net income over the last 5 years.

JYNT had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

JYNT has a worse Return On Assets (-6.82%) than 70.30% of its industry peers.

JYNT has a worse Return On Equity (-21.48%) than 65.35% of its industry peers.

		Industry Rank	Sector Rank
ROA	-6.82%
ROE	-21.48%
ROIC	N/A

ROA(3y)-7.05%

ROA(5y)1.52%

ROE(3y)-28.39%

ROE(5y)0.48%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

JYNT's Gross Margin of 81.48% is amongst the best of the industry. JYNT outperforms 95.05% of its industry peers.

In the last couple of years the Gross Margin of JYNT has declined.

JYNT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	81.48%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-4.87%

GM growth 5Y-2.53%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

JYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for JYNT has been increased compared to 1 year ago.

Compared to 5 years ago, JYNT has more shares outstanding

There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

JYNT has an Altman-Z score of 3.19. This indicates that JYNT is financially healthy and has little risk of bankruptcy at the moment.

JYNT has a better Altman-Z score (3.19) than 64.36% of its industry peers.

There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	3.19

ROIC/WACCN/A

WACC8.76%

2.3 Liquidity

JYNT has a Current Ratio of 1.80. This is a normal value and indicates that JYNT is financially healthy and should not expect problems in meeting its short term obligations.

With a decent Current ratio value of 1.80, JYNT is doing good in the industry, outperforming 65.35% of the companies in the same industry.

A Quick Ratio of 1.80 indicates that JYNT should not have too much problems paying its short term obligations.

JYNT has a better Quick ratio (1.80) than 66.34% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.8
Quick Ratio	1.8

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

JYNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.41%, which is quite impressive.

Looking at the last year, JYNT shows a decrease in Revenue. The Revenue has decreased by -9.68% in the last year.

The Revenue has been growing slightly by 1.36% on average over the past years.

EPS 1Y (TTM)72.41%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%53.85%

Revenue 1Y (TTM)-9.68%

Revenue growth 3Y-13.43%

Revenue growth 5Y1.36%

Sales Q2Q%-56.15%

3.2 Future

JYNT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 73.24% yearly.

JYNT is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -20.57% yearly.

EPS Next Y97.68%

EPS Next 2Y91.85%

EPS Next 3Y73.24%

EPS Next 5YN/A

Revenue Next Year-54.02%

Revenue Next 2Y-28.81%

Revenue Next 3Y-20.57%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JYNT. In the last year negative earnings were reported.

A Price/Forward Earnings ratio of 26.94 indicates a quite expensive valuation of JYNT.

The rest of the industry has a similar Price/Forward Earnings ratio as JYNT.

When comparing the Price/Forward Earnings ratio of JYNT to the average of the S&P500 Index (22.86), we can say JYNT is valued inline with the index average.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	26.94

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as JYNT.

		Industry Rank	Sector Rank
P/FCF	45.19
EV/EBITDA	N/A

4.3 Compensation for Growth

JYNT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

JYNT's earnings are expected to grow with 73.24% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y91.85%

EPS Next 3Y73.24%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for JYNT!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

JOINT CORP/THE

NASDAQ:JYNT (9/19/2025, 8:24:36 PM)

After market: 9.96 0 (0%)

9.96

-0.3 (-2.92%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)08-07 2025-08-07/amc

Earnings (Next)11-05 2025-11-05/amc

Inst Owners74.55%

Inst Owner Change5.03%

Ins Owners7.04%

Ins Owner Change3.9%

Market Cap152.79M

Analysts78.18

Price Target15.17 (52.31%)

Short Float %3.99%

Short Ratio8.61

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-1.93%

Min Revenue beat(2)-2.34%

Max Revenue beat(2)-1.53%

Revenue beat(4)1

Avg Revenue beat(4)-12.67%

Min Revenue beat(4)-51.14%

Max Revenue beat(4)4.33%

Revenue beat(8)3

Avg Revenue beat(8)-6.08%

Revenue beat(12)4

Avg Revenue beat(12)-4.64%

Revenue beat(16)6

Avg Revenue beat(16)-3.78%

PT rev (1m)-3.25%

PT rev (3m)-3.25%

EPS NQ rev (1m)-100%

EPS NQ rev (3m)-100%

EPS NY rev (1m)-115%

EPS NY rev (3m)-104.35%

Revenue NQ rev (1m)-1.03%

Revenue NQ rev (3m)-3.38%

Revenue NY rev (1m)-1.62%

Revenue NY rev (3m)-1.84%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	26.94
P/S	1.41
P/FCF	45.19
P/OCF	32.21
P/B	6.58
P/tB	6.58
EV/EBITDA	N/A

EPS(TTM)-0.24

EYN/A

EPS(NY)0.37

Fwd EY3.71%

FCF(TTM)0.22

FCFY2.21%

OCF(TTM)0.31

OCFY3.1%

SpS7.07

BVpS1.51

TBVpS1.51

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-6.82%
ROE	-21.48%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	81.48%
FCFM	3.12%

ROA(3y)-7.05%

ROA(5y)1.52%

ROE(3y)-28.39%

ROE(5y)0.48%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-4.87%

GM growth 5Y-2.53%

F-Score6

Asset Turnover1.48

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Debt/EBITDA	N/A
Cap/Depr	52.4%
Cap/Sales	1.26%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.8
Quick Ratio	1.8
Altman-Z	3.19

F-Score6

WACC8.76%

ROIC/WACCN/A

Cap/Depr(3y)57.36%

Cap/Depr(5y)93.23%

Cap/Sales(3y)6.25%

Cap/Sales(5y)6.57%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)72.41%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%53.85%

EPS Next Y97.68%

EPS Next 2Y91.85%

EPS Next 3Y73.24%

EPS Next 5YN/A

Revenue 1Y (TTM)-9.68%

Revenue growth 3Y-13.43%

Revenue growth 5Y1.36%

Sales Q2Q%-56.15%

Revenue Next Year-54.02%

Revenue Next 2Y-28.81%

Revenue Next 3Y-20.57%

Revenue Next 5YN/A

EBIT growth 1Y-162.07%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year302.99%

EBIT Next 3Y74.18%

EBIT Next 5YN/A

FCF growth 1Y-70.37%

FCF growth 3Y6.31%

FCF growth 5Y15.29%

OCF growth 1Y-71.9%

OCF growth 3Y-12.05%

OCF growth 5Y4.6%

JOINT CORP/THE (JYNT) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens